By publishing more than 200 complete response letters, the FDA is offering new visibility into the issues that most often ...

Saint Louis University’s Center for Vaccine Development is asking for 70 adult volunteers to participate a clinical trial ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

Discover how Masdar City in Abu Dhabi is at the forefront of autonomous vehicle technology with real-world testing of Level 4 driverless cars. Learn about the implications for smart mobility, city ...

Considering a migraine clinical trial? Learn about the types, benefits, risks, and eligibility, along with what questions you should ask to see if participating is right for you.

AL amyloidosis is caused by abnormal plasma cells in the bone marrow, which produce misfolded amyloid proteins that circulate in the blood, then build-up in the heart, kidney, liver, and other organs.

The FDA granted fast track designation to TRE-515 plus radioligand therapy for treating PSMA-positive metastatic ...

Findings from a Phase I trial initiated by Dana-Farber Cancer Institute have showed NeoVaxMI's improved immune response in melanoma patients.

Adalimumab and other biologic therapies for hidradenitis suppurativa show similar efficacy for treating the disease.

Central Asia’s land, water, and ecosystems face extreme pressure from farming, population growth, and pollution.

Recent ASCO 2025 findings reveal new insights into melanoma treatment, highlighting challenges and advancements in adjuvant ...

Digital technology may be on the verge of ‘breaking out’ for schizophrenia treatment, but numerous questions will need to be ...